CLSA Events

Mission Bay Open House and Panel Discussion

This joint QB3 and BayBio event will provide a rare opportunity for Northern California life sciences companies to tour core facilities at UCSF Mission Bay and to learn about the state-of-the-art support services and technologies they provide, as well as their availability to aid commercial scientific research and investigative teams. A distinguished panel of experts will examine the benefits of industry, academia and venture collaboration for improving translational research following the tours.

What: Mission Bay Open House and Panel Discussion
When: June 29, 2010
UCSF Core Facilities Tours and Poster Sessions:
3:00pm – 5:00pm
Panel Discussion: Mission Bay on a Mission:
5:00pm – 6:00pm
Networking Reception:
6:00 – 7:00pm
Where: UCSF Mission Bay
1700 4th St, Byers Hall, San Francisco, CA
Directions
Parking: Garage parking available $3/hr
Attire: Business attire suggested
Cost: SOLD OUT | Tours Only:
$20 BayBio Members | $40 Non-Members
SOLD OUT | Tours, Panel Discussion and Reception:
$40 Members | $75 Non-Members
UCSF Core Facilities Participating in Tours and Poster Sessions:

Nikon Imaging Center**
Cell Culture Facility
Core Immunoassay Laboratory
Small Molecule Discovery Center**
MicroCT
NMR Center**
Center for BioEntrepreneurship
Lab for Cell Analysis**
Preclinical Therapeutics
Lentiviral Core
ARI-UCSF Laboratory of Clinical Virology
CFAR CTSI-TTR Core Immunology Laboratory
CTSI Clinical Research Services
DNA Bank
Earl Miller Radiologic Imaging Laboratory
Genomics Core Facility
Gladstone Genomics Core
Gladstone Histology Core
Gladstone Stem Cell Core
Human Islet and Cellular Transplantation Facility
Neurobehavioral Core for Rehabilitation Research
Preclinical Fluorescence Imaging Laboratory
Biomagnetic Imaging Core

**Participating in core facility tours

Panel Discussion:
Mission Bay on a Mission

A panel of remarkable biotech leaders will explore how unique collaboration between university, venture capital and corporations can improve translational medicine and accelerate bringing improved products and services to society. The panel will explore how these partners in life science product development can be matched more efficiently, and how product development costs can be lowered and R&D process can be further de-risked.

Panel Participants:

Brook Byers
Partner, Kleiner Perkins Caufield & Byers

Susan Desmond-Hellmann
Chancellor, UCSF

Regis Kelly
Director, QB3

Gail Maderis
President and CEO, BayBio

Uwe Schoenbeck
CSO, BioTherapeutics External R&D Innovation, Pfizer, Inc.

Therapeutics Series Sponsors

Bayer Healthcare QB3 Merck M Squared Consulting